Exposure to perfluoroalkyl and polyfluoroalkyl substances and risk of stroke in adults: a meta-analysis
- PMID: 37656598
- DOI: 10.1515/reveh-2023-0021
Exposure to perfluoroalkyl and polyfluoroalkyl substances and risk of stroke in adults: a meta-analysis
Abstract
Introduction: Evidence of the adverse metabolic health effects of perfluoroalkyl and polyfluoroalkyl substances (PFAS) is increasing. However, the impact of PFAS on cardiovascular diseases remains controversial. This meta-analysis aimed to analyze the impact of PFAS on the stroke risk.
Content: Databases were searched for studies published up to November 1, 2022, which report the association between stroke and exposure to at least one of four main PFAS (perfluorooctanoic acid [PFOA], perfluorooctanesulfonic acid [PFOS], perfluorononanoic acid [PFNA], and perfluorohexane sulfonic acid [PFHxS]). Data extraction and quality assessment were performed according to the Newcastle-Ottawa scale.
Summary and outlook: Four studies were included in this systematic review. Multivariate adjusted odds ratios (ORs) for incident stroke per 1-log unit increment in each serum PFAS were combined in the meta-analysis. The risk of development of stroke was not significantly associated with PFOA, PFOS, or PFNA exposure (PFOA: pooled odds ratio [OR]=1.001, 95 % confidence interval [CI]=0.975-1.028, p=0.934; PFOS: pooled OR=0.994, 95 % CI=0.972-1.017, p=0.601; PFNA: pooled OR=1.016, 95 % CI=0.920-1.123, p=0.752), whereas a moderately lower risk was associated with PFHxS exposure without statistical significance (pooled OR=0.953, 95 % CI=0.908-1.001, p=0.054). PFOA, PFOS, and PFNA exposure showed a neutral association, while PFHxS showed a possible inverse association with the risk of stroke. Therefore, this finding should be interpreted with caution. Further prospective observational studies with PFAS mixture analyses are warranted.
Keywords: Endocrine disrupting chemicals; meta-analysis; perfluorinated compounds; perfluoroalkyl and polyfluoroalkyl substances; stroke.
© 2023 Walter de Gruyter GmbH, Berlin/Boston.
Similar articles
-
Associations between per- and poly-fluoroalkyl substance (PFAS) exposure and immune responses among women in the California Teachers study: A cross-sectional evaluation.Cytokine. 2024 Dec;184:156753. doi: 10.1016/j.cyto.2024.156753. Epub 2024 Sep 18. Cytokine. 2024. PMID: 39299102
-
Associations between per- and polyfluoroalkyl substance exposure and the prevalence of myopia in adolescents: the mediating role of serum albumin.Environ Health Prev Med. 2025;30:50. doi: 10.1265/ehpm.25-00023. Environ Health Prev Med. 2025. PMID: 40571595 Free PMC article.
-
Sex specificity in associations between exposure to a mixture of per and poly-fluoroalkyl substances and anxiety among US adults.J Expo Sci Environ Epidemiol. 2025 Jul;35(4):578-589. doi: 10.1038/s41370-024-00741-3. Epub 2025 Jan 7. J Expo Sci Environ Epidemiol. 2025. PMID: 39775104
-
The effects of perfluoroalkyl and polyfluoroalkyl substances on female fertility: A systematic review and meta-analysis.Environ Res. 2023 Jan 1;216(Pt 3):114718. doi: 10.1016/j.envres.2022.114718. Epub 2022 Nov 2. Environ Res. 2023. PMID: 36334833
-
Association between per- and polyfluoroalkyl substances exposure and risk of diabetes: a systematic review and meta-analysis.J Expo Sci Environ Epidemiol. 2023 Jan;33(1):40-55. doi: 10.1038/s41370-022-00464-3. Epub 2022 Aug 15. J Expo Sci Environ Epidemiol. 2023. PMID: 35970987
Cited by
-
TLR4 as a Potential Target of Me-PFOSA-AcOH Leading to Cardiovascular Diseases: Evidence from NHANES 2013-2018 and Molecular Docking.Toxics. 2024 Sep 25;12(10):693. doi: 10.3390/toxics12100693. Toxics. 2024. PMID: 39453113 Free PMC article.
-
Fish consumption benefits and PFAS risks: Epidemiology and public health recommendations.Toxicol Rep. 2024 Sep 19;13:101736. doi: 10.1016/j.toxrep.2024.101736. eCollection 2024 Dec. Toxicol Rep. 2024. PMID: 39391711 Free PMC article. Review.
References
-
- Lau, C, Anitole, K, Hodes, C, Lai, D, Pfahles-Hutchens, A, Seed, J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007;99:366–94. https://doi.org/10.1093/toxsci/kfm128 . - DOI
-
- Winquist, A, Steenland, K. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts. Epidemiology 2014;25:255–64. https://doi.org/10.1097/ede.0000000000000040 . - DOI
-
- Fenton, SE, Ducatman, A, Boobis, A, DeWitt, JC, Lau, C, Ng, C, et al.. Per-and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research. Environ Toxicol Chem 2021;40:606–30. https://doi.org/10.1002/etc.4890 . - DOI
-
- Grandjean, P, Heilmann, C, Weihe, P, Nielsen, F, Mogensen, UB, Budtz-Jorgensen, E. Serum vaccine antibody concentrations in adolescents exposed to perfluorinated compounds. Environ Health Perspect 2017;125:077018. https://doi.org/10.1289/ehp275 . - DOI
-
- Girardi, P, Merler, E. A mortality study on male subjects exposed to polyfluoroalkyl acids with high internal dose of perfluorooctanoic acid. Environ Res 2019;179:108743. https://doi.org/10.1016/j.envres.2019.108743 . - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical